Stay updated with breaking news from Jeffrey Bacha. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
The medication, Orotecan®, is a novel oral formulation of irinotecan, an intravenous drug that has demonstrated efficacy in treating various pediatric and adult cancers.
Rakovina Therapeutics Inc (TSX-V:RKV), a Canadian biotechnology company focused on developing innovative therapies for the treatment of cancer, experienced...
VANCOUVER, British Columbia, April 09, 2024 -- Rakovina Therapeutics Inc. , , a biopharmaceutical company dedicated to improving the lives of cancer patients through the development of novel...
Rakovina Therapeutics Inc. , ("Rakovina" or the "Company"), a biopharmaceutical company dedicated to improving the lives of cancer patients through the development of novel DNA-damage response inhibitor therapeutics, is pleased to announce a...
Company Leveraging Deep Docking AI Drug Discovery PlatformVANCOUVER, British Columbia, March 27, 2024 -- Rakovina Therapeutics Inc. , , a biopharmaceutical company dedicated to improving the lives...